Teicoplanin Completed Phase 2 Trials for Osteoarticular Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01815541Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study